Main Results of the last years for the benefit of the Host-Organizations

Pathohistology and assessment of the mineralization for routine diagnostic purposes; development of efficient and accurate methods for differential diagnosis ( bone histomorphometry, qBEI, sSAXS)

Bone 2003, 32:316-323 (qBEI)
J. Appl. Cryst. 2000, 33:820-823 (sSAXS, sWAXD)
Wien Med Wochenschr 1999, 16/17:463-471 (differential diagnosis)
Calcif Tiss Int 1999, 64:422-429 (sSAXS)
Bone 1998, 23:319-326 (qBEI)

Assessment of bone biopsies from patients with rare bone diseases (Pycnodysostosis, Osteogenesis Imperfecta, M. Paget)

JCEM 2004, in print (Pycnodysostosis)
JBMR 2003, 18 suppl 2:S411 abstract WG9 (Osteogenesis Imperfecta)
Bone 2001, 29:453-457 (Osteogenesis Imperfecta)
Praktische Rheumatologie 2001 (contribution to textbook) (M. Paget)

Assessment of fracture risk and selection of targeted treatment on an individual basis (Alendronate, PTH, NaF)

JCEM 2003, 88:1150-1156 (PTH)
Bone 2001, 29:185-191 (Alendronate)
Osteologie 1998, 7:130-133 (NaF)

Establishment of normative data for bone mineral density, assessment of the vitamin D and Calcium nutritional status in the Austrian population and of incidence and costs of osteoporosis-associated hip fractures in Austria

Eur. J. Clin. Invest 2003, 33:323-331 (vitamin D, Ca)
Eur. J. Clin. Invest 2003, 33:332-339 (BMD)
Wien Klin Wochenschr 2001, 113:371-377 (hip fracture)

Assistance of LBIO-staff with the development of systematic reviews, guidelines, and disease management plans for the Austrian and German Health Insurance Systems

DVO - Evidenz-basierte Konsensus-Leitlinien zur Osteoporose (www.bergmannsheil.de/leitlinien-dvo)
Wien Med Wochenschr 2002, 23/24:596-612